USPSTF I Statement vs D Grade: What They Mean

What is the difference between a USPSTF I statement and a D grade?

A USPSTF I statement means evidence is insufficient to determine a preventive service's balance of benefits and harms; a D grade recommends against it because there is moderate or high certainty of no net benefit or greater harms than benefits. Neither is a personal test result. Discuss individual decisions with a clinician. Concerning symptoms need clinical assessment, not waiting for routine screening; suspected life-threatening problems require emergency help.

The difference is between an unresolved evidence judgment and a recommendation against a service. Reading both as “not recommended” loses information that matters in a clinical conversation.

For a suspected life-threatening problem, MedlinePlus advises calling 911 in the United States; elsewhere, use the local emergency number. Do not use this reading exercise to delay urgent care.

This guide explains terminology using the USPSTF's currently published definitions, checked September 7, 2026. It does not select a screening test, determine eligibility or supply a screening schedule.

Who are these recommendations written for?

The U.S. Preventive Services Task Force, or USPSTF, evaluates clinical preventive services. Its scope statement limits recommendations to people without signs or symptoms of the specific condition being evaluated, for services offered in or referred from primary care.

That condition-specific boundary is important. A routine screening recommendation cannot answer why someone has a new symptom. The recommendations are intended to support decisions between patients and primary care clinicians, not to replace that conversation.

The grade belongs to a defined preventive service in a stated population. It is not a score for a person's health, a diagnosis, or a universal judgment about every possible use of a test. Our screening-versus-diagnosis guide explains the difference between the questions those processes address.

What does an I statement actually mean?

Under the USPSTF's grade definitions after July 2012, an I statement means the available evidence cannot establish the balance of benefits and harms. The evidence may be missing, poor in quality or conflicting.

“I” is therefore not a finding that the service has no benefit. It is also not evidence that the service is harmless. Neither favorable nor unfavorable assumptions fill the information gap.

The Task Force directs readers to the recommendation's clinical considerations. If the service is offered, the patient should understand the uncertainty about benefits and harms. Whether a service fits one person's circumstances remains a clinical decision.

Ask a clinician to explain what is uncertain in the particular statement. A useful question is “Which part of the evidence is insufficient?” rather than “Does I mean I should arrange this myself?”

What does a D grade mean?

The D definition begins: “The USPSTF recommends against the service.” Its stated basis is moderate or high certainty that net benefit is absent or that harms exceed benefits. The accompanying practice guidance discourages use.

This is different from being unable to determine the balance. Do not soften a D grade into “researchers have not decided yet.” Equally, do not translate it into “every individual will be harmed.” It is a recommendation about the service and population described.

Bring questions about how the statement applies to your care to a qualified clinician. Do not cancel diagnostic follow-up or disregard symptoms because you saw a D attached to a screening recommendation.

The definitions and practice suggestions are from the USPSTF page linked above; personal application requires clinical judgment.

How can certainty be high when benefit is low?

Certainty and benefit are different concepts. Section 6 of the USPSTF procedure manual separates confidence in the evidence assessment from the size of the net benefit.

Net benefit concerns benefits after considering harms. Certainty concerns confidence in that assessment. The manual explicitly allows high certainty alongside a small or even zero net benefit. Stronger evidence does not automatically mean a more favorable recommendation.

Evidence assessment also concerns the whole connection between the preventive service and health outcomes, not merely whether a test can detect something. Read the rationale for the particular statement instead of substituting a claim about test accuracy for the complete judgment.

These terms are not numbers for a home calculation. This guide gives no personal risk score or percentage chance that a test will help you.

Why does the recommendation discuss harms?

The benefits and harms under discussion are health consequences, not simply whether taking the test is inconvenient.

NIH's screening overview describes false-positive results, missed disease and overdiagnosis. Overdiagnosis means identifying a real disease that would not have caused problems during the person's lifetime; it can lead to treatment that the person would otherwise not have received.

That is distinct from a false positive, where the test incorrectly indicates disease. Keep those terms separate when asking about a screening decision.

NIH also advises discussing screening with a doctor and reporting worrying symptoms between screenings. A previous negative result is not a reason to ignore concerning symptoms. Questions about an existing result, new symptoms or treatment belong with the clinician responsible for your care, not with a grade-comparison chart.

Which parts of the actual statement should you read?

Open the full official recommendation, not only a screenshot of its letter. Use a short source note:

• Exact title and the preventive service being evaluated.
• The population named in the relevant recommendation row.
• Publication date and whether the document is draft, final or an older version.
• The grade or I statement attached to that specific row.
• The rationale and clinical or practice considerations.
• The question you need your clinician to answer.

The USPSTF procedure manual's recommendation section explains that one topic may receive different grades for specific subpopulations. It also describes evidence or methodological changes that can change a grade.

Do not merge the audience from one row with the grade from another. Do not present a draft as a final statement. When versions appear to conflict, keep their labels and dates visible and ask which applies.

Our public-health guidance reading guide covers issuer and version checks in more detail.

Can you practice spotting the difference without choosing a test?

This is a fictional reading exercise. It describes no real test, patient, disease, study or USPSTF recommendation. It is not a method for grading evidence yourself.

Suppose two practice cards contain these summaries:

• Card A: The available research does not establish the balance of benefits and harms for the stated preventive service and population.
• Card B: There is moderate certainty that the stated service has no net benefit in the population described.

Using the published grading framework, Card A corresponds to the logic of an I statement. Card B corresponds to the logic of a D grade. The Task Force's recommendation grid places moderate or high certainty with zero or negative net benefit in the D category.

Now assess three conclusions:

1. “Card A proves the service is safe.” Unsupported. Uncertainty about balance does not establish safety.
2. “Card B means the evidence is merely missing.” Incorrect. Its stated judgment is no net benefit with moderate certainty.
3. “Either card tells me what to do about a new symptom.” Incorrect. Symptoms require clinical assessment; a preventive-service summary does not supply it.

The point is to preserve the difference in meaning, not to turn a fictional card into a real-world instruction.

What questions should you take to a clinician?

Use the recommendation as a shared reference, then ask:

• “Are we discussing routine screening or investigating a symptom or previous result?”
• “Which population and recommendation row are relevant to this discussion?”
• “What does the statement say is known, and what remains uncertain?”
• “What benefits, harms and possible follow-up should I understand?”
• “What is the agreed next step, and whom should I contact with further concerns?”

These are our suggested question prompts, not a replacement for a consultation. They deliberately omit a self-selected interval, eligibility calculation or treatment decision.

MedlinePlus recommends discussing health information with a health care provider before relying on it, even when the source appears trustworthy. Keep the official link and your unanswered question together. You do not need to turn a private medical history into a public worksheet.

The practical result of careful reading is a more precise conversation: uncertainty stays uncertainty, a recommendation against stays a recommendation against, and personal care stays with qualified clinicians. Further Screening Basics articles explain related result and follow-up language.

Sources

• USPSTF: grade definitions, including the after-July-2012 definitions.
• USPSTF: scope and purpose.
• USPSTF procedure manual, Section 6: evidence certainty and net benefit.
• USPSTF procedure manual, Section 7: recommendation grades and formulation.
• NIH News in Health: screening benefits, harms and symptom follow-up.
• MedlinePlus: evaluating health information.
• MedlinePlus: emergency medical services.